Carlos F. Santos

RetinaPharma Technologies, Inc. is a development stage biotechnology company. Its mission is to become a world leader in the prevention, diagnosis and treatment of neurologically based conditions of the retina, brain, spinal cord and peripheral nerves by offering clinically beneficial and incrementally superior drug carriers, pharmaceuticals and related devices based upon its intellectual property and proprietary technology.

Accentia Biopharmaceuticals, Inc. engages in the commercialization of patent-protected disruptive healthcare technologies. It offers products under the BiovaxID., Revimmune, and SinuNase brands. The company was founded in 2002 and is headquartered in Tampa, FL.

BioVest International, Inc. develops and commercializes personalized therapeutic cancer vaccine for the treatment of B-cell blood cancers. The firm continued development, commercialization, manufacture and sale of AutovaxID and other instruments and disposables; and the commercial sale and production of cell culture products and services. The company was founded in 1981 and is headquartered in Tampa, FL.

Aperta Biosciences LLC provides biotechnology services. The company was founded by Carlos F. Santos and is headquartered in Austin, TX.